Back to top
more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

96.59
692,880

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Revvity's (PKI) Q1 Earnings Top, '23 View Below Expectations

Revvity's (PKI) first-quarter results reflect the impact of transition following divestment of AES business. While earnings outpace estimates, sales miss the same.

PerkinElmer (PKI) Q1 Earnings Surpass Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of 2.02% and 1.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Revvity (PKI) This Earnings Season?

Revvity (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Waters (WAT) Lags Q1 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of -4.23% and 1.55%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Revvity (PKI) to Report Q1 Earnings: Is a Beat in the Cards?

Revvity's (PKI) first-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.

John Blank headshot

Finding Top Computer & Tech Stocks: Zacks May Strategy

The Info Tech sector remains a key 2023 returns source. In turn, using the Price to Sales forward 12-month stock valuation ratio is helpful to identify top Computer and Technology stocks.

McKesson (MCK) to Report Q4 Earnings: Is a Beat in Store?

McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.

PerkinElmer (PKI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

PerkinElmer (PKI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bruker (BRKR) Beats Q1 Earnings and Revenue Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 16.36% and 7.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Will PerkinElmer (PKI) Beat Estimates Again in Its Next Earnings Report?

PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

UBER Set to Report Q1 Earnings: Here's What You Should Know

The Delivery unit is likely to have aided UBER's Q1 performance.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain from a solid product portfolio despite forex woes.

PerkinElmer (PKI) Completes Divestment, New Business Name in Q2

PerkinElmer (PKI) completes separation of its businesses into two entities ¿¿¿ the AES business, and the Life Sciences and Diagnostics business.

PerkinElmer's (PKI) Latest Launch to Boost Research Workflows

PerkinElmer's (PKI) latest launch is expected to provide increased assay flexibility to researchers.

PerkinElmer's (PKI) Q4 Earnings Top, Revenues Decline Y/Y

PerkinElmer's (PKI) fourth-quarter results benefit from the solid performance of the Discover & Analytics Solutions business, more than offset by lower COVID-related sales.

PerkinElmer (PKI) Beats Q4 Earnings and Revenue Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of 2.41% and 1.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

PerkinElmer (PKI) to Post Q4 Earnings: What's in the Cards?

PerkinElmer's (PKI) fourth-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for discovery business, and informatics franchise.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain from a solid product portfolio despite forex woes.

Zacks Industry Outlook Highlights Mettler-Toledo, PerkinElmer and Waters

Mettler-Toledo, PerkinElmer and Waters have been highlighted in this Industry Outlook article.

Aniruddha Ganguly headshot

3 Instruments Stocks to Watch From a Challenging Industry

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Waters (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand despite lingering effects of COVID-19.

Why Is PerkinElmer (PKI) Up 10.3% Since Last Earnings Report?

PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain from solid product portfolio despite forex woes.

PerkinElmer's (PKI) New Viral Vector Assays to Boost Workflows

PerkinElmer's (PKI) latest launch is expected to help researchers expand options to measure viral titers, unlike ELISA and other wash-based systems.

PerkinElmer's (PKI) New Marketing Approval to Aid Infant Health

PerkinElmer's (PKI) EONIS SCID-SMA assay kit is expected to enable early SMA and SCID screening in newborns following the FDA's approval.

PerkinElmer (PKI) Q3 Earnings Top, Revenues Decline Y/Y

PerkinElmer's (PKI) third-quarter results benefit from the solid performance of the Discover & Analytics Solutions business, which was more than offset by lower COVID-related sales.